Loading...
A recent study showed that paroxetine, a selective serotonin reuptake inhibitor (SSRI), had a lower rate of adverse effects than nortriptyline in depressed patients with stable ischemic heart disease (see JW March 1, 1998, p.39, or JAMA 1998; 279:287). Now a study examines the cardiac effects of another SSRI, fluoxetine, in 27 depressed patients (mean age, 73) with various other cardiac abnormalities.
After two weeks of fluoxetine (20 mg daily), there was no drop in ejection fraction (EF) among 12 patients with baseline reduced ventricular function (mean EF, 35 percent); no change in QRS interval for 18 patients with a baseline prolonged QRS duration (mean, 0.125 seconds); and no change in number of ventricular premature beats (VPBs) in 16 p…